{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:58:28Z","timestamp":1769248708660,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,6]]},"DOI":"10.7759\/cureus.40025","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T17:34:32Z","timestamp":1686072872000},"source":"Crossref","is-referenced-by-count":2,"title":["Identification of a TP53 Mutation in a Patient With Li-Fraumeni Syndrome and Not Meeting the Revised Chompret Criteria: A Case Report"],"prefix":"10.7759","author":[{"given":"Monika","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torahiko","family":"Jinta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg T","year":"2020","unstructured":"Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet. 2020, 28:1379-86. 10.1038\/s41431-020-0638-4","journal-title":"Eur J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard G","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, et al.. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015, 33:2345-52. 10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026187","article-title":"Inherited TP53 mutations and the Li-Fraumeni syndrome","author":"Guha T","year":"2017","unstructured":"Guha T, Malkin D. Inherited TP53 mutations and the Li-Fraumeni syndrome. Cold Spring Harb Perspect Med. 2017, 10.1101\/cshperspect.a026187","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-013-0020-0","article-title":"Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"Sorrell AD","year":"2013","unstructured":"Sorrell AD, Espenschied CR, Culver JO, Weitzel JN. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther. 2013, 17:31-47. 10.1007\/s40291-013-0020-0","journal-title":"Mol Diagn Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly MB","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al.. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021, 19:77-102. 10.6004\/jnccn.2021.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02011-w","article-title":"Medical guidelines for Li-Fraumeni syndrome 2019","volume":"26","author":"Kumamoto T","year":"2021","unstructured":"Kumamoto T, Yamazaki F, Nakano Y, et al.. Medical guidelines for Li-Fraumeni syndrome 2019. Int J Clin Oncol. 2021, 26:2161-78. 10.1007\/s10147-021-02011-w","journal-title":"Int J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.496759","article-title":"Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US","volume":"28","author":"Cronin KA","year":"2010","unstructured":"Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R. Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest. 2010, 28:963-8. 10.3109\/07357907.2010.496759","journal-title":"Cancer Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94403-1","article-title":"Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan","volume":"11","author":"Abdel-Razeq H","year":"2021","unstructured":"Abdel-Razeq H, Abujamous L, Abunasser M, Edaily S, Bater R. Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan. Sci Rep. 2021, 11:14906. 10.1038\/s41598-021-94403-1","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05612-7","article-title":"Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome","volume":"181","author":"Le AN","year":"2020","unstructured":"Le AN, Harton J, Desai H, et al.. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Breast Cancer Res Treat. 2020, 181:181-8. 10.1007\/s10549-020-05612-7","journal-title":"Breast Cancer Res Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159995-identification-of-a-tp53-mutation-in-a-patient-with-li-fraumeni-syndrome-and-not-meeting-the-revised-chompret-criteria-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:45Z","timestamp":1707508845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159995-identification-of-a-tp53-mutation-in-a-patient-with-li-fraumeni-syndrome-and-not-meeting-the-revised-chompret-criteria-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.40025","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,6]]}}}